Cargando…
Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer
Objective: The objective of this study is to identify and validate novel therapeutic target(s) in ovarian cancer. Background: Development of targeted therapeutics in ovarian cancer has been limited by molecular heterogeneity. Although gene expression datasets are available, most of them lack appropr...
Autores principales: | Ulm, Michael A., Redfern, Tiffany M., Wilson, Ben R., Ponnusamy, Suriyan, Asemota, Sarah, Blackburn, Patrick W., Wang, Yinan, ElNaggar, Adam C., Narayanan, Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712057/ https://www.ncbi.nlm.nih.gov/pubmed/33256002 http://dx.doi.org/10.3390/jpm10040246 |
Ejemplares similares
-
Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers
por: Ulm, Michael, et al.
Publicado: (2019) -
Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancer
por: Narayanan, Ramesh, et al.
Publicado: (2017) -
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
por: Mohler, Michael L., et al.
Publicado: (2021) -
Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancer
por: Condello, Salvatore, et al.
Publicado: (2022) -
Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells
por: Bruney, Lana, et al.
Publicado: (2016)